(Q54485692)

30 May 2018

title

Modulation of constitutive and inducible hepatic cytochrome(s) P-450 by interferon beta in mice. (English)

1 reference

30 May 2018

author name string

Carelli M

1

1 reference

30 May 2018

Porras MC

2

1 reference

30 May 2018

Rizzardini M

3

1 reference

30 May 2018

Cantoni L

4

1 reference

30 May 2018

publication date

1 February 1996

1 reference

30 May 2018

published in

Journal of Hepatology

1 reference

30 May 2018

volume

24

1 reference

30 May 2018

issue

2

1 reference

30 May 2018

page(s)

230-237

1 reference

30 May 2018

The pharmacology and toxicology of the interferons: an overview

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980034-1

7 January 2021

Structure of interferons.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980034-1

7 January 2021

Interferons in the therapy of solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980034-1

7 January 2021

Interferons for the treatment of hematological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980034-1

7 January 2021

Combined zidovudine and interferon-alpha treatment in patients with AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980034-1

7 January 2021

Systemic alpha-interferon therapy of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980034-1

7 January 2021

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980034-1

7 January 2021

Homogeneous interferon from E. coli depresses hepatic cytochrome P-450 and drug biotransformation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980034-1

7 January 2021

Depression of hepatic cytochrome P-450-dependent monooxygenase systems with administered interferon inducing agents

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980034-1

7 January 2021

Depression of theophylline elimination following BCG vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980034-1

7 January 2021

Inhibition of theophylline metabolism by interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980034-1

7 January 2021

The prevention of acetaminophen-induced hepatotoxicity by the interferon inducer poly(rI . rC)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980034-1

7 January 2021

Differential effects of phenobarbitone and 3-methylcholanthrene induction on the hepatic microsomal metabolism and cytochrome P-450-binding of phenoxazone and a homologous series of its n-alkyl ethers (alkoxyresorufins)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980034-1

7 January 2021

Identification of the cytochrome P-450 induced by macrolide antibiotics in rat liver as the glucocorticoid responsive cytochrome P-450p

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980034-1

7 January 2021

“Western Blotting”: Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980034-1

7 January 2021

Mouse liver phenobarbital-inducible P450 system: purification, characterization, and differential inducibility of four cytochrome P450 isozymes from D2 mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980034-1

7 January 2021

Regulation of two electrophoretically distinct proteins recognized by antibody against rat liver cytochrome P450 3A1

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980034-1

7 January 2021

Differential effects of recombinant interferon α on constitutive and inducible cytochrome P450 isozymes in mouse liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980034-1

7 January 2021

Depression of liver drug metabolism and increase in plasma fibrinogen by interleukin 1 and tumor necrosis factor: a comparison with lymphotoxin and interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980034-1

7 January 2021

Methoxyresorufin and benzyloxyresorufin: substrates preferentially metabolized by cytochromes P4501A2 and 2B, respectively, in the rat and mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980034-1

7 January 2021

Interleukin 2 induction of cytochrome P450-linked monooxygenase systems of rat liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980034-1

7 January 2021

Human cytochromes P450: problems and prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980034-1

7 January 2021

Catalytic selectivity of human cytochrome P450 enzymes: relevance to drug metabolism and toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980034-1

7 January 2021

Turnover of membrane proteins: kinetics of induction and degradation of seven forms of rat liver microsomal cytochrome P-450, NADPH-cytochrome P-450 reductase, and epoxide hydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980034-1

7 January 2021

10.1016/S0168-8278(96)80034-1

Identifiers

DOI

1 reference

30 May 2018

1 reference

30 May 2018